Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

DAILY RECAP · FORM 4 FILINGS

Insider trading recap: October 20, 2026

On October 20, 2026, insiders filed 24 open-market purchases worth $19.6M across 22 companies, and 53 sales worth $55.0M, on SEC Form 4. The largest purchase was Nippon Life Insurance Co (10% Owner) buying $12.1M of Corebridge Financial, Inc. (CRBG) at an average $34.71 a share. The largest sale was Deboer Scott J (Pres. & Chief Tech & Prod Offr) selling $25.7M of MICRON TECHNOLOGY INC (MU) under a 10b5-1 plan. 2 companies had several insiders buying on the same day: DYNEX CAPITAL INC (DX), Nova Minerals Corp (NVA).

The write-up, company by company: insider buying on October 20, 2026 · insider selling on October 20, 2026.

$19.6MInsider buying24 purchases by 20 insiders
$55.0MInsider selling53 sales, 33 under 10b5-1 plans
7CEO / CFO buyschief executive or finance officer
2Cluster buys2+ insiders, same company
LARGEST PURCHASES

Biggest insider buys filed October 20, 2026

Open-market purchases, one row per Form 4, largest first.

Largest insider purchases filed October 20, 2026
CompanyInsiderValueSharesAvg priceTraded
CRBG Corebridge Financial, Inc.Nippon Life Insurance Co 10% Owner · 10b5-1$12.1M347,195$34.71Oct 16, 2026
SCISX MA Specialty Credit Income FundMA Eagle II Holdings Fund 10% Owner$2.4M96,931$24.76Oct 16, 2026
LEO BNY MELLON STRATEGIC MUNICIPALS, INC.Saba Capital Management, L.P. 10% Owner$1.9M338,104$5.65Oct 16, 2026
DSM BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.Saba Capital Management, L.P. 10% Owner$1.1M207,722$5.28Oct 16, 2026
JOF JAPAN SMALLER CAPITALIZATION FUND INCSaba Capital Management, L.P. 10% Owner$552K46,222$11.94Oct 16, 2026
ECF ELLSWORTH GROWTH & INCOME FUND LTDSaba Capital Management, L.P. 10% Owner$386K33,426$11.56Oct 16, 2026
BOLD Boundless Bio, Inc.Tang Kevin 10% Owner$350K149,474$2.34Oct 16, 2026
GF NEW GERMANY FUND INCSaba Capital Management, L.P. 10% Owner$311K30,088$10.33Oct 16, 2026
DX DYNEX CAPITAL INCPopenoe Smriti Laxman Co-CEO and President, Director$157K12,000$13.05Oct 20, 2026
GRF EAGLE CAPITAL GROWTH FUND, INC.Sims David C CFO, CCO, Secretary, Treasurer, Director$109K10,787$10.07Oct 16, 2026
XGN EXAGEN INC.Chernett Jorey 10% Owner$104K14,000$7.46Oct 19, 2026
NXG NXG NextGen Infrastructure Income FundSunderland Todd Portfolio Manager$47K1,000$46.50Oct 19, 2026
NBIS Nebius Group N.V.Grimme Arne Director · 10b5-1$25K148$169.99Oct 19, 2026
AYI ACUITY INC. (DE)O'Shaughnessy Laura Director$22K73$302.32Oct 16, 2026
NVA Nova Minerals CorpGerteisen Christopher Chief Executive Officer, Director$22K6,737$3.26Oct 16, 2026
CLUSTER BUYS

Several insiders buying the same stock

Companies where two or more insiders filed purchases this day. All cluster buys.

Cluster buys filed October 20, 2026
CompanyInsidersValue
DX DYNEX CAPITAL INC2$167K
NVA Nova Minerals Corp2$27K
LARGEST SALES

Biggest insider sales filed October 20, 2026

Selling has many routine reasons (taxes, diversification, planned 10b5-1 sales), so read these as context.

Largest insider sales filed October 20, 2026
CompanyInsiderValueSharesAvg priceTraded
MU MICRON TECHNOLOGY INCDeboer Scott J Pres. & Chief Tech & Prod Offr · 10b5-1$25.7M28,545$900.00Oct 16, 2026
GRND Grindr Inc.Zage George Raymond III Director, 10% Owner · 10b5-1$7.1M500,000$14.12Oct 16, 2026
UTHR UNITED THERAPEUTICS CorpRothblatt Martine A Chairperson & CEO, Director · 10b5-1$5.2M9,500$543.32Oct 19, 2026
VG Venture Global, Inc.Thayer Jonathan W Chief Financial Officer · 10b5-1$2.8M222,222$12.69Oct 19, 2026
CRSP CRISPR Therapeutics AGKulkarni Samarth Chief Executive Officer, Director$2.4M47,837$49.78Oct 19, 2026
AVPT AvePoint, Inc.Brown Brian Michael Chief Legal Officer, Director · 10b5-1$1.2M76,106$15.26Oct 16, 2026
GWRE Guidewire Software, Inc.Mullen John P President · 10b5-1$999K5,400$185.00Oct 20, 2026
GLBE Global-E Online Ltd.Schlachet Amir CEO, Director · 10b5-1$976K24,999$39.04Oct 16, 2026
PRCH Porch Group, Inc.Neagle Matthew Chief Operating Officer · 10b5-1$713K40,625$17.56Oct 16, 2026
ORKA Oruka Therapeutics, Inc.Quinlan Paul T General Counsel · 10b5-1$707K9,000$78.53Oct 20, 2026

Grouped by the day the Form 4 reached SEC EDGAR. Values are shares times the reported price; a price far from the market close is treated as a typo and left out. Not investment advice.